Page last updated: 2024-11-02

phenobarbital and Cephalgia Syndromes

phenobarbital has been researched along with Cephalgia Syndromes in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
" All patients were effectively treated with no serious adverse events."1.32Oral phenobarbital loading: a safe and effective method of withdrawing patients with headache from butalbital compounds. ( Biondi, D; Loder, E, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loder, E1
Biondi, D1
LANCE, JW1
CURRAN, DA1

Other Studies

2 other studies available for phenobarbital and Cephalgia Syndromes

ArticleYear
Oral phenobarbital loading: a safe and effective method of withdrawing patients with headache from butalbital compounds.
    Headache, 2003, Volume: 43, Issue:8

    Topics: Administration, Oral; Barbiturates; Behavior Therapy; Clinical Protocols; Combined Modality Therapy;

2003
TREATMENT OF CHRONIC TENSION HEADACHE.
    Lancet (London, England), 1964, Jun-06, Volume: 1, Issue:7345

    Topics: Amitriptyline; Amobarbital; Anxiety; Anxiety Disorders; Biomedical Research; Chlordiazepoxide; Diaze

1964